Intravitreal faricimab treatment for traumatic choroidal rupture and macular neovascularization in angioid streaks: A case report.

Eur J OphthalmolDec 24, 2025 (epub)
Case ReportOphthalmology

Riccardo Fasana, Nathalie Skovgaard Eriksen, Enrico Borrelli et al.

✦ AI-curated · Sources linked

Case in brief

A patient developed visual symptoms after blunt ocular trauma. Examination identified angioid streaks with macular neovascularization (MNV) and a traumatic rupture; family history prompted genetic evaluation, which diagnosed pseudoxanthoma elasticum. The MNV was treated with three intravitreal faricimab injections at four-week intervals. The report describes excellent visual results and no exudative recurrence during the eight months after the final injection.

What made this case unusual

The case combined traumatic rupture and MNV associated with angioid streaks, and reports outcomes with faricimab for these lesions.

Diagnostic / clinical pearl

In a patient with visual symptoms after blunt trauma, examination may reveal angioid streaks with MNV and traumatic rupture; family history can prompt evaluation for an associated systemic condition such as pseudoxanthoma elasticum.

Source

Published in Eur J Ophthalmol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.